# Study of T900607-Sodium in Previously Treated Patients With Non-Hodgkin's Lymphoma.

> **NCT00043459** · PHASE2 · TERMINATED · sponsor: **Tularik** · enrollment: 35 (—)

## Conditions studied

- Non-Hodgkin's Lymphoma

## Interventions

- **DRUG:** intravenous T900607-sodium

## Key facts

- **NCT ID:** NCT00043459
- **Lead sponsor:** Tularik
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2002-07
- **Primary completion:** —
- **Final completion:** 2003-03
- **Target enrollment:** 35 (—)
- **Last updated:** 2005-06-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00043459

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00043459, "Study of T900607-Sodium in Previously Treated Patients With Non-Hodgkin's Lymphoma.". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00043459. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*